NEW ORLEANS, Sept. 19, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 25, 2017 to file lead plaintiff applications in a securities class action lawsuit against Zebra Technologies Corporation (Nasdaq:ZBRA), if they purchased the Company’s shares between March 17, 2015 and May 9, 2016, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Zebra Technologies investors should visit us at https://www.claimsfiler.com/cases/view-zebra-technologies-corporation-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Zebra Technologies and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 10, 2016, Zebra announced that its Q1 2016 financial results were “below . . . expectations, with lower sales and earnings reflecting the continuation of a cautious enterprise spending environment.” However, that same day, Zebra revealed that problems had been identified in its internal controls in 2015 that had impacted its ability to accurately forecast its pretax income and deferred taxes.
On this news, the price of Zebra’s shares plummeted more than $11 per share.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



